Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer

Abstract

BackgroundPatients presenting with stage IVB cervical cancer pose a significant clinical challenge. While previous studies described several poor prognostic factors, they were limited by small sample sizes. The aim of this study was to identify clinicopathological prognostic factors in a large sample of patients with stage IVB cervical cancer at a single institution.MethodsPatients with primary stage IVB cervical cancer diagnosed between 1992 and 2011 were extracted from a search of the MD Anderson Cancer Center registry. Clinicopathological data retrieved from their medical records included demographics (age and race), tumor characteristics (primary lesion size, grade, and histology), TNM classification, and metastatic site (nodal/organ). Treatment approach (radiation, chemotherapy, or both) and intent (palliation or curative) were recorded. Survival rates were evaluated using the Kaplan-Meier method. Cox proportional hazards regression was used to model the association between key variables and overall survival (OS).ResultsTwo hundred sixty-six patients with stage IVB cervical cancer were identified. Their median OS was 12.7 months. The hazard ratio for African-Americans vs. patients with other ethnicities was 1.76 (95% confidence interval [CI], 1.18–2.54, P = 0.0063), and that for patients with para-aortic nodes alone vs. more extensive metastases was 0.37 (95% CI, 0.26–0.51, P < 0.0001). Other clinicopathological factors were not significantly associated with survival.ConclusionsAfrican-American race was an independent adverse prognostic factor in this cohort. On the other hand, nodal disease in the para-aortic chain alone predicted a favorable prognosis.

Effect of primary radiotherapy on the survival rate of stage IVB cervical cancer patients and factors related to their survival: a real-world study based on SEER database

“…Nishio et al [36] stated that racial differences in cervical cancer incidence and death rates were indisputable, consistent with our findings showing that racial differences affected patients' OS. However, the reasons for racial differences in mortality rates remain unclear and controversial.…”

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri

“…Stage IIIC1 cervical cancer is not a single disease entity, and local tumor factors remain the primary determinant of survival. Nishio et al [6] showed that the prognosis of women with cervical cancer with extra-pelvic metastasis varies based on metastatic sites outside of the pelvis. Specifically, outcomes for metastatic cervical cancer solely in the para-aortic LNs are superior when compared to cervical cancer metastasized to other extra-pelvic sites.…”

Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study

“…Patients who develop distant metastases are rarely curable. The 5-year survival of stage IVB patients is poor and approximately 50% of these patients show a fatal outcome within 1 year [345].…”